PHYRAGO
- Product NDC
- 70709-156
- 11-digit product format
- 707090156
- Labeler code
- 70709
- Product ID
- 70709-156_c853d4c8-8373-4603-bc62-41e53130c0aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dasatinib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cycle Pharmaceuticals Ltd
- Application
- NDA216099
- Marketing category
- NDA
- Marketing start
- 2025-09-22
- Substance
- DASATINIB
- Active strength
- 140 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PHYRAGO
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DASATINIB | 140 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406, 2691837, 2691839, 2691841, 2691843, 2691845, 2691847 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70709-156-14 | PHYRAGO | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70709-156-14 | 70709015614 | 30 TABLET in 1 BOTTLE (70709-156-14) | 30 tablet | 2025-09-22 | No | No | Historical |